Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Cantor Fitzgerald
Farmers Insurance
Queensland Health
Cipla
Teva
US Department of Justice
McKesson

Generated: June 22, 2018

DrugPatentWatch Database Preview

Pharmacia And Upjohn Company Profile

« Back to Dashboard

Summary for Pharmacia And Upjohn
International Patents:289
US Patents:8
Tradenames:108
Ingredients:84
NDAs:133
Drug Master File Entries: 41

Drugs and US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-001 Dec 29, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn NEO-MEDROL ACETATE methylprednisolone acetate; neomycin sulfate CREAM;TOPICAL 060611-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn NORMIFLO ardeparin sodium INJECTABLE;INJECTION 020227-002 May 23, 1997 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn MEDROL methylprednisolone TABLET;ORAL 011153-004 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 3,426,067 ➤ Try a Free Trial
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-001 Jan 27, 1998 5,501,673 ➤ Try a Free Trial
Pharmacia And Upjohn SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106-002 Mar 25, 2003 5,350,836 ➤ Try a Free Trial
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-003 Jan 27, 1998 4,968,299 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PHARMACIA AND UPJOHN drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 600 mg ➤ Subscribe 2005-12-21
➤ Subscribe Oral Suspension 100 mg/5 mL ➤ Subscribe 2009-08-03
➤ Subscribe Injection 2 mg/mL, 100 mL bag ➤ Subscribe 2009-12-29
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe 2007-07-30
➤ Subscribe Injection 2 mg/mL, 300 mL bag ➤ Subscribe 2009-09-01

Non-Orange Book US Patents for Pharmacia And Upjohn

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,444,813 Linezolid-crystal form II ➤ Try a Free Trial
7,008,637 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder ➤ Try a Free Trial
6,517,864 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Pharmacia And Upjohn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1214076/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
00221 Netherlands ➤ Try a Free Trial PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
C/GB00/027 United Kingdom ➤ Try a Free Trial PRODUCT NAME: INSULIN ASPART AND PROTAMINE (NOVOMIX 30); REGISTERED: CH 55414 01 20000623; CH 55415 02 20000623; CH 55416 02 20000623; UK EU/1/00/142/001-008 20000801
70039 Netherlands ➤ Try a Free Trial PRODUCT NAME: [1R-[1 ALPHA (Z),2 BETA(R*),3 ALPHA,5ALPHA]]-7-[3,5-DIHYDROXY-2-(3-HYDROXY-5- FENYLPENTYL)CYCLOPENTYL]-5-HEPTEENZUUR, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN ESTER, IN HET BIJZONDER LATANOPROSTUM; NAT. REGISTRATION NO/DATE: RVG 21304 19970610; FIRST REGISTRATION: SE 12716 19960718
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Chinese Patent Office
Baxter
Fish and Richardson
Federal Trade Commission
Merck
Healthtrust
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.